Physician profile
Jennifer Henle
NPI 1639278328
$1,408.18
in general payments reported to CMS, 2019-2025
18 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $243 · 2021: $149 · 2022: $201 · 2023: $189 · 2024: $106 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $471.62 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Abbvie INC. | $199.65 | 2019-2022 | |
| Sanofi Pasteur INC. | $111.18 | 2019-2025 | |
| Genentech USA, INC. | $108.92 | 2019-2022 | |
| Kaleo, INC. | $106.39 | 2019-2023 | Auvi-Q |
| Corium, LLC | $70.57 | 2022 | |
| Merck Sharp & Dohme LLC | $60.69 | 2023-2024 | Vaxneuvance, Gardasil 9, M-M-R II |
| Takeda Pharmaceuticals U.S.A., INC. | $54.04 | 2020-2021 | |
| Amgen INC. | $40.12 | 2019-2020 | |
| Antares Pharma, INC. | $24.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.57 | 2019 | |
| Ironshore Pharmaceuticals INC. | $23.90 | 2019 | |
| Adlon Therapeutics L.P. | $21.64 | 2019 | |
| Hologic Sales and Service, LLC | $19.85 | 2025 | Aptima |
| Welch Allyn | $19.60 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $18.86 | 2020 | |
| Sobi, INC | $17.97 | 2019 | |
| Seqirus USA INC | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Henle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.